Join to invest

Already registered? Log in

113%

Winner of SIX awards in 2021, NGX BodyFuel is The World’s First Genetically Personalised Meal-Shake (patent pending). After successfully launching and selling over 120,000 meals in the UK, NGX is raising capital to open the US market & accelerate the launch of new personalised nutrition products.

  • Customer numbers grown 560% in 2021 & return on ad spend of £3.78 for every £1 spent
  • Dragon's Den Winner
  • Large & Fast Growing Meal Replacement Market est $24.8bn by 2025 (7% CAGR)
  • 6x Awards for Innovation, Excellence & Best in Nutrition

Idea

Everyone is genetically unique, with unique nutrition requirements. Current food supplements are often based on generic food guidelines that are unsuitable for achieving optimal levels of fitness & health. It used to be complex & expensive to determine an individual's unique nutrition targets. And it used to be a hassle to prepare fresh food every day to hit them - especially for busy people.

NGX BodyFuel is The World's First Genetically Personalised Meal-Shake, our patent-pending solution to this problem, based on a simple, at-home DNA Nutrition Test.

We have collected ~1m+ customer data points, sold 120,000+ meals of BodyFuel, developed proprietary gene-nutrition matching technology & for the last 6 months have achieved an average return on ad spend of £3.78 for every £1 spent.

We have secured partnerships with the likes of AMEX, Barclays, F45, Axa & Everyone Active. We have featured in the likes of Vogue, Men's Fitness, Women's Health & Dragon's Den - winning offers from Peter Jones & Touker Suleyman.

Our vision is to perfect individual nutrition, whoever you are, whatever your goal. We use our deep understanding of customer genetics & lifestyle choices to inform our R&D roadmap that aims to improve both customer health, & customer value to NGX.

We are raising with the aim of accelerating customer acquisition, launching new products & establishing a US market presence.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the NGX pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered?
Log in

Risk warning

Investing in start-ups and early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Crowdcube is targeted exclusively at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. You will only be able to invest via Crowdcube once you are registered as sufficiently sophisticated. Please click here to read the full Risk Warning.

Crowdcube is authorised and regulated by the Financial Conduct Authority (FCA) and the Comisión Nacional del Mercado de Valores (CNMV). This page has been approved by Crowdcube. Pitches for investment are not offers to the public and investments can only be made by members of crowdcube.com on the basis of information provided in the pitches by the companies concerned. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

NGX has been given advance assurance by HMRC that the proposed share issue is likely to qualify for Enterprise Investment Scheme (EIS) tax relief.

Tax relief is available to individuals only, with income tax relief currently set at 30 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More.

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.